ECSP045074A - HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS - Google Patents
HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORSInfo
- Publication number
- ECSP045074A ECSP045074A ECSP045074A ECSP045074A EC SP045074 A ECSP045074 A EC SP045074A EC SP045074 A ECSP045074 A EC SP045074A EC SP045074 A ECSP045074 A EC SP045074A
- Authority
- EC
- Ecuador
- Prior art keywords
- hiv
- hydroxypirimidinone
- carboxamide
- inhibitors
- replaced
- Prior art date
Links
Abstract
La presente invención está dirigida a hidroxipirimidinona carboxamidas novedosas. Estos compuestos son útiles en la inhibición de la integrasa de VIH, la prevención de la infección por VIH, el tratamiento de la infección por VIH y en la prevención, tratamiento y retraso de la aparición de SIDA y/o ARC, ya sea como compuestos o sus sales farmacéuticamente aceptables o hidratos (cuando sea apropiado), o como ingredientes de la composición farmacéutica, y sea o no en combinación con otros antivirales de VIH/SIDA, anti-infecciosos, inmunomoduladores, antibióticos o vacunas. Más particularmente, la presente invención incluye un compuesto de la Fórmula (I) cuya descripción de elementos se encuentra en la primera reivindicación.The present invention is directed to novel hydroxypyrimidinone carboxamides. These compounds are useful in inhibiting HIV integrase, preventing HIV infection, treating HIV infection and preventing, treating and delaying the onset of AIDS and / or ARC, either as compounds. or its pharmaceutically acceptable salts or hydrates (when appropriate), or as ingredients of the pharmaceutical composition, whether or not in combination with other HIV / AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. More particularly, the present invention includes a compound of Formula (I) whose description of elements is found in the first claim.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP045074 ECSP045074A (en) | 2004-04-22 | 2004-04-22 | HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP045074 ECSP045074A (en) | 2004-04-22 | 2004-04-22 | HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP045074A true ECSP045074A (en) | 2004-05-28 |
Family
ID=40435097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP045074 ECSP045074A (en) | 2004-04-22 | 2004-04-22 | HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP045074A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9296769B2 (en) | 2011-08-16 | 2016-03-29 | Gilead Sciences, Inc. | Tenofovir alafenamide hemifumarate |
-
2004
- 2004-04-22 EC ECSP045074 patent/ECSP045074A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9296769B2 (en) | 2011-08-16 | 2016-03-29 | Gilead Sciences, Inc. | Tenofovir alafenamide hemifumarate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022007527A (en) | Kras mutant protein inhibitors. | |
DK1753723T3 (en) | Substituted quinoline derivatives as mitotic kinesin inhibitors | |
ECSP066826A (en) | HIV INTEGRAS INHIBITORS | |
TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
HUP0401740A2 (en) | N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase and pharmaceutical compositions containing them | |
MX2009005881A (en) | Non-nucleoside reverse transcriptase inhibitors. | |
TN2009000243A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
MXPA05011411A (en) | Substituted 1,4-diazepines and uses thereof. | |
MY152271A (en) | Novel compounds that are erk inhibitors | |
EA200970291A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM | |
CR9694A (en) | HIV REVERSE TRANSCRIPT INHIBITORS | |
MX2020009234A (en) | Heteroaryl compounds as type ii irak inhibitors and uses hereof. | |
NO20090405L (en) | Non-nucleoside reverse transcriptase inhibitors | |
EA201290976A1 (en) | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | |
BRPI0408353A (en) | compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound | |
EA201170537A1 (en) | HIV INTEGRASE INHIBITORS | |
PH12019500394A1 (en) | Bicyclic nitrogenated heterocyclic compound | |
CR20220251A (en) | New methylquinazolinone derivatives | |
MY195881A (en) | Griseofulvin Compound | |
PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
TW200624429A (en) | Novel cysteine protease inhibitors | |
MX2009010932A (en) | Non-nucleoside reverse transcriptase inhibitors. | |
EP1539714A4 (en) | 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors | |
ECSP045074A (en) | HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS | |
DOP2006000176A (en) | HIV REVERSE TRANSCRIPT INHIBITORS |